- Interventional
- Observational
- Expand Access
Decentralized Clinical Trials Market size was valued at USD 1,675.5 million in 2022 and is expected to grow USD 4,508.2 million in 2029, at a CAGR of 9.8% from 2023 to 2029. A study executed through telemedicine, mobile, and local healthcare providers using a process of technology differing from the traditional clinical method approach is known as a decentralized clinical trial. The market is segmented on study design and includes interventional, observational, and expanded access data, observational data are mainly collected from healthcare providers and telemedicine providers. The DCT market is a fast-growing market that provides incorporation with digital clinical trials. The DCT models provide benefits to patients and sponsors as compared to traditional clinical trials. The demand for accurate and high-quality data enhanced patient convenience and experience, lowered the burden of travel, and decreased time-consuming in-patient visits are the major factors driving the market of decentralized clinical trials market. Regulatory agencies are following various factors for decentralized clinical trials to approach but there is no international standard, which increases the demand for sponsorship for decentralized clinical trials, Although, the reimbursement policies by the government are the key opportunities in the overall Decentralized clinical trials market. Controlling costs, approval from a government authority, recruitment of participants, retaining participants, and completing of trial on time are the major challenges in the decentralized clinical trial. The adoption of artificial intelligence tools for clinical trials is a major recent trend in the market.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
The increasing prevalence of mobile healthcare and the increase in sponsorship in a clinical trials in the world is the major market driver in the Decentralized Clinical Trials Market during the forecast period. Enhanced patient convenience towards health care and skilled professional for health consultants are major demand in the market, also in pharmaceutical to increase research and development activity, with this increasing number of clinical trials and high cost for drug manufacturing also in R&D facility, are dependent on data and information from outsourced firms, increased in the demand for sponsorship for decentralized clinical trials. Hence, this will drive global market growth at a significant rate.
The Decentralized clinical trials market size was valued at USD 1,675.5 million in 2022 and expected to reach USD 4,508 million in 2028, growing at an 9.8% CAGR from 2023 to 2029
A study executed through telemedicine, mobile, and local healthcare providers using the process of technology differs from the traditional clinical method approach is known as a decentralized clinical trial.
The leading players in the Decentralized Clinical Trials Market are; Medidata, IQVIA, LabCorp, PRA Health Sciences, Parexel, ICON, Oracle, CRF Health, Clinical Ink, Medable, Science 37, LEO Innovation Lab, Covance, Thermo Fisher, Huma, Signant Health
Historic years considered for the market study are 2018 through 2022, 2022 is considered as the base year for market estimation, and Seven years forecast is presented from 2023 – 2029.
1.Executive Summary |
2.Global Decentralized Clinical Trials Market Introduction |
2.1.Global Decentralized Clinical Trials Market - Taxonomy |
2.2.Global Decentralized Clinical Trials Market - Definitions |
2.2.1.Study Design |
2.2.2.Application |
2.2.3.End User |
2.2.4.Region |
3.Global Decentralized Clinical Trials Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Decentralized Clinical Trials Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Decentralized Clinical Trials Market By Study Design, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
5.1. Interventional |
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Observational |
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Expand Access |
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6.Global Decentralized Clinical Trials Market By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
6.1. Peripheral Vascular Disease |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Oncology |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Neurology |
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Urology |
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Others |
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7.Global Decentralized Clinical Trials Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
7.1. Hospitals |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Ambulatory Surgical Centers |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Diagnostic Centers |
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Others |
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8.Global Decentralized Clinical Trials Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Decentralized Clinical Trials Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
9.1. Study Design Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Interventional |
9.1.2.Observational |
9.1.3.Expand Access |
9.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Peripheral Vascular Disease |
9.2.2.Oncology |
9.2.3.Neurology |
9.2.4.Urology |
9.2.5.Others |
9.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospitals |
9.3.2.Ambulatory Surgical Centers |
9.3.3.Diagnostic Centers |
9.3.4.Others |
9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Decentralized Clinical Trials Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
10.1. Study Design Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Interventional |
10.1.2.Observational |
10.1.3.Expand Access |
10.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Peripheral Vascular Disease |
10.2.2.Oncology |
10.2.3.Neurology |
10.2.4.Urology |
10.2.5.Others |
10.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals |
10.3.2.Ambulatory Surgical Centers |
10.3.3.Diagnostic Centers |
10.3.4.Others |
10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
11.Asia Pacific (APAC) Decentralized Clinical Trials Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
11.1. Study Design Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Interventional |
11.1.2.Observational |
11.1.3.Expand Access |
11.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Peripheral Vascular Disease |
11.2.2.Oncology |
11.2.3.Neurology |
11.2.4.Urology |
11.2.5.Others |
11.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals |
11.3.2.Ambulatory Surgical Centers |
11.3.3.Diagnostic Centers |
11.3.4.Others |
11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Decentralized Clinical Trials Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
12.1. Study Design Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Interventional |
12.1.2.Observational |
12.1.3.Expand Access |
12.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Peripheral Vascular Disease |
12.2.2.Oncology |
12.2.3.Neurology |
12.2.4.Urology |
12.2.5.Others |
12.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals |
12.3.2.Ambulatory Surgical Centers |
12.3.3.Diagnostic Centers |
12.3.4.Others |
12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Decentralized Clinical Trials Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
13.1. Study Design Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Interventional |
13.1.2.Observational |
13.1.3.Expand Access |
13.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Peripheral Vascular Disease |
13.2.2.Oncology |
13.2.3.Neurology |
13.2.4.Urology |
13.2.5.Others |
13.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals |
13.3.2.Ambulatory Surgical Centers |
13.3.3.Diagnostic Centers |
13.3.4.Others |
13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Medidata |
14.2.2.IQVIA |
14.2.3.LabCorp |
14.2.4.PRA Health Sciences |
14.2.5.Parexel |
14.2.6.ICON |
14.2.7.Oracle |
14.2.8.CRF Health |
14.2.9.Clinical Ink |
14.2.10.Medable |
14.2.11.Science 37 |
14.2.12.LEO Innovation Lab |
14.2.13.Covance |
14.2.14.Thermo Fisher |
14.2.15.Huma |
14.2.16.Signant Health |
15. Research Methodology |
16. Appendix and Abbreviations |